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Abstract 
 
The present study deals with standardization of an in-house standard preparation and three marketed samples of 
Brahmi vati, which is a traditional medicine known to be effective in mental disorders, convulsions, weak memory, high 
fever and hysteria. Preparation and standardization have been done by following modern scientific quality control procedures 
for raw material and the finished products. The scanning electron microscopic (SEM) analysis showed the reduction of 
metals and minerals (particle size range 2-5 μm) which indicates the proper preparation of bhasmas, the important ingredient 
of Brahmi vati.  Findings of EDX analysis of all samples of Brahmi vati suggested the absence of Gold, an important 
constituent of Brahmi vati in two marketed samples. All the samples of Brahmi vati were subjected to quantitative estimation 
of Bacoside A (marker compound) by HPTLC technique. Extraction of the samples was done in methanol and the 
chromatograms were developed in Butanol: Glacial acetic acid: water (4.5:0.5:5 v/v) and detected at 225nm. The regression 
analysis of calibration plots of Bacoside A exhibited linear relationship in the concentration range of 50-300 ng, while the % 
recovery was found to be 96.06% w/w, thus proving the accuracy and precision of the analysis. The Bacoside A content in 
the in-house preparation was found to be higher than that of the commercial samples. The proposed HPTLC method was 
found to be rapid, simple and accurate for quantitative estimation of Bacoside A in different formulations. The results of this 
study could be used as a model data in the standardization of Brahmi vati.  
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Introduction 
 
Ayurveda, the ancient system of plant based medicines is gaining recognition throughout the world and many 
herbal drugs are now clinically tested and accepted for manufacturing (Gold frank L, et al 1982; Vulto A.G, et al 1988). 
However, one of the impediments in the acceptance of the ancient systems of medical preparation is the lack of standard 
quality control profiles (Bagul and Rajani, 2005). The quality of herbal medicine, that is, the profile of the constituents in the 
final product has implication in efficacy and safety. Due to the complex nature and inherent variability of the chemical 
constituents of the plant based drugs, it is difficult to establish quality control parameters therefore modern analytical 
techniques are expected to help in circumventing this problem. Ayurvedic medicines prepared in the form of tablets or pills 
are known as Vati and Gutika. These are made of one or more drugs of plant, animal or mineral origin. Brahmi vati (BV), a 
polyherbo-mineral formulation, consists of Brahmi (Bacopa monnieri) and another thirty six ingredients including nine 
bhasmas and pisties. The formulation is official in  the Ayurvedic Formulary of India, Part II and claimed to be 
therapeutically useful in the treatment of all types of mental disorders, vertigo, heart weakness, high fever, convulsion, 
hysteria and mental weakness (The Ayurvedic Formulary of India, 1976).  In the present study, one batch of BV was 
prepared in laboratory with standard materials (IBV) and three commercial samples (BV1, BV2 and BV2) from market were 
collected. These four samples were subjected to physico-chemical, pharmaceutical and energy dispersive X ray spectroscopy 
analysis (EDX). The amount of Bacoside A — one of the saponine of Brahmi — was analyzed quantitatively in all four 
samples. These parameters can be compared with any commercial formulation available in the market for evaluating its 
purity and quality. The proposed method has been validated as per ICH guidelines (ICH, 1994 and 1996). Bacosides are 
secondary metabolites produced by the plant. The scientists assumed bacoside A to be an indicator of the presence of brahmi 
(Marker compounds of selected Ayurvedic drugs, 2009).  
In spite of the large number of herbal formulations available in the market, standards for their quality are yet to be 
laid for many of them (Eapen Saumy M.S, et al 2002; Patel K.N, 1996). It is therefore, imperative to develop fast, sensitive 
and accurate quality control tests for Ayurvedic formulations which will be in alignment with modern technology. In the 
literature survey no scientific study has been conducted to standardize this BV so far. Hence, a scientific investigation was 
undertaken to evaluate BV.  
 
 
Materials and Methods 
 
Analytical Reagent grade butanol, glacial acetic acid and methanol were obtained from S.D. Fine Chem 
Ltd.(Mumbai, India). Pure Bacoside A was obtained from IIIM, Jammu, India as gift samples. Pre-coated silica gel 60 F254 
TLC aluminum plates (10 x 10 cms, 0.2 mm thick) were obtained from E.Merck Ltd. (Mumbai, India). 
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Crude herbs and minerals 
 
All required herbs and minerals (Table 1) were purchased from local markets and authenticated by Department of 
botany and department of Rasa Shashtra, Banaras Hindu University, Varanasi, India. These plant materials were standardized 
following The Ayurvedic Pharmacopoeia of India. As per the results, the low quality batches were replaced. 
 
Table 1: Ingredients of Brahmi vati 
Name of Ingredients Plant/mineral/metal name Parts used Main constituents 
Nutmeg Myristica fragrance Hoult. Seed Isoeugenol, methyl-eugenol, eugenol, myrcene, quercetin 
Clove Eugenia carophyllus Thunb. Flower bud Eugenol, eugenyl acetate, beta-caryophyllene,  tannins 
Saussurea Saussurea lappa C.B. Clarke. Root Costunolide, Isodihydrocostunolide, cynaropicrin. 
Mace Myristica fragrance Hoult. Aril/Mace α - pinene, β - pinene, limonene, linoleic acid, palmitic acid 
Caraway Carum carvi Linn. Fruit Carvacrol, carvone, α-pinene, limonene, γ-terpinene, linalool,  
Long pepper Piper longum Linn. Fruit Piperine, piperidine, piperitine, α – pinene, sesquiterpenes. 
Cinnamon Cinnamomum zeylanicum Blume. Stem bark Cinnamaldehyde ,α - pinene, β – pinene,  ethylcinnamate, eugenol  
Anise Pimpinella anisum Linn. Fruit Eugenol trans-anethole, methylchavicol, coumarins, scopoletin 
Withania Withania somnifera Dunal. Root Withanone, withaferin A, withanolide A, withanolide D 
Pallitory Anacyclus pyrethrum Linn. Root Pyrethrine, inulin, volatile oil. 
Coriander Corriandrum sativum Linn Fruit Coriandrol, borneol, citronwllol, pyrazine, pyridine, Coriandrin  
Vansalocana Bambusa  arundinacea Retz. Siliceous 
concretions 
Cellulose, pentosans , silica. 
Cardamom Elettaria cardamomum White et 
Mason. 
Seed Cineole, Borneol, Teripineol 
Sankhapuspi Evolvulas alsinoides Linn. Plant Betaine, shankhapushpine and evolvine. 
Sandal wood Centalum album Linn. Heart wood Santalol, santene, alcohols-santenol, 
Fennal Foeniculum vulgare Mill. Fruit trans-Anethole, estragole, fenchone, quercetin, arabinoside 
Patra Cinnamomum tamala Fr.Nees. Leaf Alpha-pinene, Benzaldehyde ,Beta Phellandrene, Linalool,  
Mesua Mesua ferra Linn. Steman Ferruol- A, Mesuaferrone-A, Mesuaferrone  B, Mesuein. 
Mastic Pistacia lentiscus Linn Exudate Alpha and beta masticoresins, masticin, mastic acid, masticoresen 
Pippalamula Piper longum Linn. Root Piperine, cepharadione A, cepharadione B. 
Lead War Plumbago zeylanica Linn. Root Plumbagin, naphthoquinones, binaphthoquinones, coumarins, 
Galanga Alpinia galangal Linn. Rhizome Galangin, Kaempherol, Acetoxyeugenol acetate, Hydroxychavicol  
Abelmoschus Abelmoschus moschatus Medik. Seed ((Z)-7-hexadecen-16-olide) and (Z)-5-tetradecen-14-olide 
Thyme Leaved 
Gratiola 
Bacopa monnieri Linn. Plant Bacoside A3, Bacoside II,  bacogenin A1, A2, A3,  bacopasaponins 
A, B and C, pseudojujubogenin 
Indian jalap Operculina turpethum Linn. Root Turpethin, Turpethinic acids- A, B, C, D, & E 
Eagle wood Aquilaria agollochal Roxb. Heart wood Octacosane, naphthalene. 
Saffron Crocus sativus Linn. Stigma Crocin, safranal, picrocrocin 
Abhraka bhasma Abhraka Biotite mica K(Mg,Fe)3AlSi3O10(Fe,OH)2. 
Mukta bhasma Mukta Pearl CaCO3 
Akik bhasma Akik Agate SiO2 
Praval bhasma Praval Red coral CaCO3, Mg 
Candrodaya Gandhak and parad Sulphur and 
Murcury 
S, Hg 
Svarna bhasma Svarna Gold foil Au 
Kaharuba pisti Kaharuba Amber Diterpenes (C20H32) and trienes 
Manikya pisti Manikya Ruby Al2O3 
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Commercial samples of Brahmi vati 
 
Three marketed samples of Brahmi vati were purchased from three different manufacturers from local market and  
labeled as BV1, BV2 and BV3. 
 
Preparation of bhasma and pisties 
 
For in house preparation of Brahmi vati, all minerals and metals were processed to get respective bhasma and 
pistis. The process was performed under the supervision of a Ayurvedic practitioner under standard laboratory conditions. 
Bhasma were prepared by traditional process, which involved two steps- shodhana (purification) and maran (calcinations ant 
rosting) of gem/mineral/metals with specified plant materials ( Prakash B, 1997). Akik bhasma, Abhrak bhasma, Praval 
bhasma and Mukta bhasma were prepared by this process. Kaharuba pisti, Manikya pisti and Sangryasaba pisti were prepared 
by triturating the minerals with specified plant materials (The Ayurvedic Formulary of India, 1976). Chandrodaya and 
Swarna bhasma were purchased from Ayurvedic Pharmacy, Institute of medical sciences, Banaras Hindu University, 
Varanasi. All bhasma and pistis were packed in glass bottles, labeled and stored in cool and hygienic place. SEM analysis 
was performed to check the proper preparation of bhasma which is indicated by the reduction in particle size to the micro 
meter range (Mohaptra and Jha, 2010). 
 
In-house preparation of Brahmi vati 
 
After this all plant materials were individually pulverized and sieved to find respected fine powders. For 
preparation of BV, powdered Candrodaya, Saffron, Abelmoschus and Ambara were mixed together. To this mixture, one by 
one bhasma and pistis were added and mixed well. Thereafter powders of plant materials along with fresh juice of Bacopa 
monnieri were added to the mixture and ted. Pills about 250 mg were prepared by hand rolling dried in shade and packed in 
sterilized polyethylene pouches, labeled as IBV and stored in a cool, hygienic place (Figure 1) (The Ayurvedic Formulary of 
India ,1976). 
 
Evaluation Physico-chemical and Pharmaceutical parameters 
 
For standardization of BV, physicochemical properties were evaluated for all samples (Mukharjee P.K, 2002). BV 
is a tablet formulation so pharmaceutical parameters as friability, weight variation, hardness, disintegration time were 
evaluated (Pattanayaka P, 2011; Lohar S.D, 2009) 
 
Energy dispersive X ray spectroscopy analysis  
 
As BV consists of bhasma and pistis, which are derived from minerals and metals, elemental composition of BV 
was evaluated by EDX analysis. The analysis was performed in the department of Physics, Banaras Hindu University, India. 
EDAX micro analyst, model- zaluzec with SUTW-Sapphire detector was used for this purpose. (Sudhaparimala S, et al 2011; 
Singh S.K, et al 2010). 
 
Preparation of standard solution and samples for HPTLC 
 
A reference standard solution of Bacoside A (10 μg/ml) was prepared by dissolving 1 mg of accurately weighed 
Bacoside A in methanol by sonication in ultrasonic water bath to dissolve and making up the volume to 100ml with 
methanol. The stock solution was further diluted with methanol to give a standard solution of bacoside (50ng/μl). 250 mg of 
IBV, BV1, BV2 and BV3 were extracted in methanol sapartly and extracts were sonicated, filtered through Whatman filter 
paper No1 and the final volumes were made up to 25ml with methanol. 
 
Chromatographic Conditions (For bacoside A ) 
 
Stationary phase: Pre-coated silica gel 60F254 TLC plate (10 x 10 cms, 0.2 mm thickness). Mobile phase: Butanol: 
Glacial acetic acid: water (4.5:0.5:5v/v), Saturation time: 15 minutes, Wavelength: 225nm, Lamp: Deuterium 
 
Calibration Curve 
 
The standard solutions (50-300 ng per respective spot) were applied in triplicate on TLC plate. The plate was 
developed and scanned as per the chromatographic conditions mentioned above. The peak areas were recorded. Calibration 
curve of Bacoside A was prepared by plotting peak areas vs. concentrations of Bacoside A applied. 
 
 
Analytical Procedure 
 
Methanol extracts of IBV, BV1,BV2, BV3 and standard solution of bacoside A were spotted on a 10 x 10 cm 
precoated TLC plates as 6 mm wide band and 8mm from the bottom by using Linomat V. The plates were developed in a 
twin trough chamber, under the chromatographic conditions given above, by ascending mode to a distance of 8 cm under 
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chamber saturation conditions. After development the plates were dried in air and scanned at 225 nm for bacoside A by using 
CAMAG Scanner III. The contents of Bacoside A in IBV, BV1, BV2 and BV3 were calculated from the respective 
calibration curve. 
 
 
Results 
 
SEM analysis of bhasma and pisties showed the reduction in particle size of minerals and metals in the range of 2-
5μm (Figure 2). Results of physico-chemical and pharmaceutical parameters have been presented in the table 2. Energy 
dispersive spectroscopy analysis revealed the elemental compositions of all four samples (Table 3). Gold was found absent in 
BV2 and BV3. In HPTLC, Bacoside A showed single peak at 0.62 Rf. The spot at Rf 0.60 corresponding to Bacoside A was 
observed in the chromatogram of all samples. 
There was no interference from other components present in the formulation. Good correlation was also obtained 
between standard and samples overlay spectra of Bacoside A (Figure 3) .Calibration curves was prepared by plotting 
concentrations versus average area of the peak (Fig 4 ).The linear regression analysis of calibration plots of Bacoside A 
exhibited linear relationship in the range of 50-300ng with the correlation coefficient 0.998 and thus exhibits good linearity 
between concentration and area (Table 4).Good correlation was also obtained between standard and samples overlay spectra 
of bacoside A were coloured lines represents the absorption maxima for samples and standard bacoside A(Figure 6).  
Recovery study was carried out by spiking the pre-analyzed samples with pure Bacoside A The percentage recovery of 
bacoside A was found to be 96.06%.The limit of detection was determined by signal to noise ratio which was found to be 10 
ng/spot. The formulation samples were analyzed by the proposed method. The data from Table 5 revealed that the bacoside A 
contents in IBV, BV1, BV2, BV3 were found as 1094.52±38.53, 1038.45±28.71, 523.80±12.43 and 390.64±27.80 µg/gm of 
sample respectively. 
 
                                           
Figure 1: IBV                          Figure 2: SEM analysis report of bhasma and pisties. 
 
 
 
Discussion 
 
The SEM analysis of bhasma shows reduction in the particle size to 2-5 μm range, which indicates the proper preparation of 
bhasma and is responsible for high biological activities of these metals and minerals derived substances (Wadekar M.P, et al 
2006). Reduction in particle size also facilitates absorption and assimilation of the bhasma in the system (Mohapatra and Jha, 
2010). The total ash content, which usually consists of carbonate, silicates, silica, physiological and non physiological ash, 
was found high in all samples which is due to the presence of mineral and metal derived substances in the formulation 
(Ahmad J, et al 2012). Physico-chemical parameters evaluated were found to be variable in all marketed formulations in 
comparison to the standard formulation. Values for BV1 sample were within ±5 % range of IBV while BV2 and BV3 showed 
variation in many parameters. The quality of raw material used and variation in the preparation method adopted are the 
expected reasons behind this. Friability was founded more than 1%, which is due to the absence of any binder. These 
friability values thus indicate that these tablets cannot withstand the stress associated with transportation and dispensing 
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processes (Akpabio, E. et al 2011).This can result in loss of weight due to friction. Hardness was also very less, which may 
cause breakdown of vati during transport. These parameters can be modified by the formulation of Brahmi vati. The data of 
standard formulation (IBV) may be used for standardization of Brahmi vati in future. The EDS analysis revealed the 
elemental composition of Brahmi vati. The amount of carbon (50.80-54.30% weight) represents the organic part (plant 
materials) of the vati. Other than this, the IBV contains Magnesium, Aluminum, Silica, Sulphur, Chloride, Potassium,  
 
 
Table 2: Results of physico-chemical and pharmaceutical parameters in mean (SD) ±SEM.  
Parameters  IBV  BV1  BV2  BV3  
Moisture content (%) 1.04 (0.35) ±0.17 1.08(0.73) ±0.32 1.89(0.56) ±0.23* 0.96(0.02) ±0.08* 
Water soluble extractive (%) 12.20(0.66) ±0.33 11.88(0.29) ±0.40 10.58(0.61) ±0.33* 11.45(0.54) ±0.35 
Methanol soluble extractive (%) 15.87(0.30) ±0.15 15.08(0.34) ±0.13 11.98(0.46) ±0.85* 14.61(0.78) ±0.24* 
Ash content (%) 11.41(0.37) ±0.18 10.95(0.45) ±0.19 12.04(0.32) ±0.76* 11.22(0.56) ±0.41 
Acid insoluble ash (%) 1.38(0.25) ±0.12 1.44(0.18) ±0.27 2.34(0.21) ±0.11* 1.41(0.32) ±0.15 
pH 6.45(0.36) ±0.18 6.60(0.18) ±0.34 7.32(0.80) ±0.36* 6.55(0.43) ±0.22 
Ether soluble extractive (%) 9.47(0.35) ±0.17 8.96(0.11) ±0.21 6.73(0.46) ±0.72* 7.43(0.63) ±0.31* 
Sulphated ash (%) 13.26(0.82) ±0.41 12.66(0.42) ±0.84 12.79(0.62) ±0.54 13.12(0.25) ±0.11 
Crude fiber (%) 10.65(0.60) ±0.30 11.03(0.13) ±0.93 11.47(0.45) ±0.21* 10.23(0.61) ±0.39 
Total yeast & mould count (col/g) 
(Stand.limit-103/g) 
Within the standard 
limit 
Within the standard 
limit 
Within the standard 
limit 
Within the standard 
limit 
Total aerobic count(col/g) (Stand.limit-
105/g) 
Within the standard 
limit 
Within the standard 
limit 
Within the standard 
limit 
Within the standard 
limit 
Average weight (g)(Sample size=10 vati) 0.253(0.004) ±0.002 0.254(0.007) ±0.006 0.258(0.006) ±0.007  0.257(0.003) ±0.005 
Hardness (kg/cm2) 0.82(0.20) ±0.10 0.78(0.15) ±0.32 0.98(0.41) ±0.24* 0.76(0.30) ±0.21* 
Disintegration time (sec) 149.5(18.48) ±9.24 152.2(18.12) ±9.94 159.6(14.23) ±8.28* 148(12.59±11.24 
Friability (%) 2.5(0.29) ±0.14* 2.6(0.22) ±0.15* 2.8(0.36) ±0.16* 2.3(0.32) ±0.11 * 
* Values out of ±5% range of IBV. 
Table 3: Elemental composition of Brahmi vati in % weight (IBV, BV1, BV2, BV3) 
 IBV BV1 BV2 BV3 
C 52.80       50.80 52.10 54.30 
O 09.40 09.70 07.30* 07.80* 
Mg 05.20 05.10 03.80* 04.20* 
Al 03.90 05.70* 05.10* 06.80* 
Si 09.70 10.20* 10.50* 06.80* 
S 03.90 04.90* 04.70* 04.10* 
Cl 03.70 03.60 03.60 03.50 
K 03.90 01.40* 03.30* 02.40* 
Ca 06.20 05.80* 06.60 07.60 
Au 00.30   00.30 - - 
Hg 00.10  00.50* 01.90* 01.20* 
* Values out of ±5% range of IBV. 
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Figure 3: Chromatogram of Bacoside A and BV                                                Figure 4: Calibration curve of Bacoside A        
1. Bacoside A, 2. BV1, 3. BV2, 4. BV3, 5. In-house Brahmi vati.      
 
                               
Figure 6: Spectra comparison of bacoside A for samples and                           Figure 5: Photo plate scanned at254nm 
 standard                                                                                                            1. Bacoside A, 2. BV1, 3. BV2, 4. BV3, 5.IBV                                    
  
 Table 4: Bacoside A content in different samples of Brahmi vati 
 S.No. Samples Bacoside A  Mean± SD(μg/gm of BV) 
1 IBV- In-house Brahmi vati  1094.52±38.53 
2 BV1- Marketed sample 1  1038.45±28.71 
3 BV2- Marketed sample 2  523.80±12.43* 
4 BV3- Marketed sample 3  390.64±27.80* 
* Values out of ±5% range of IBV. 
Table 5: Results of Recovery study 
Sl.No Amount of 
sample taken 
(mg)A 
Amount of 
Bacoside A in 
A 
(ng)B 
Amount of 
Bacoside A 
added to A 
(ng)C 
Amount of 
Bacoside A 
taken B+C 
(ng)D 
Total Bacoside A 
found (Mean ± SD, 
n=5) 
(ng)E 
% 
Recovery 
E/DX100 
1 250 277 50 327 311±8.45 95.10 
2 350 285 100 385 371±10.23 96.36 
3 450 292 200 492 476±9.38 96.74 
Average Recovery: 96.06% 
Table 6: Results of Validation Method 
Analytical Method Accuracy(% 
recovery) 
Precision. 
(S.D) 
Linearity Coefficient of 
variation%(CV) 
HPTLC of Bacoside A 96.06 0.6884 50-300 ng 0.3564 
 
 
Calcium, Gold and Mercury .These trace quantities of minerals along may play an important role in the functioning of 
various enzymes in biological systems and have immunomodulatory functions and thus influence the susceptibility to the 
course and the outcome of a variety of viral infections (Chaturvedi, U.C. et al 2004). There was absent of Gold in BV1 and 
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BV2, which indicates the absence of Swarna bhasma in Brahmi vati which is a very important ingredient of vati and have 
many pharmacological properties (Singh and Chaudhary, 2011). Mercury was found comparatively in high amount in BV1, 
BV2 and BV3( more than+5% ). Intake of high amount of mercury can cause memory loss, including Alzheimer like 
dementia, disruption of fine motor function and decreases rate of fertility etc (Zahir, F. et al 2005). The study revealed that 
the marketed samples of brahmi vati contain significant amounts of Bacoside A, but only one of three (BV1) in±5 % range of 
the standard preparation. This indicates the genuineness of BV1 formulations. Collected from different places, season of 
collection, storage condition and authenticity of crude herbs affects the yield of the marker compound present in it. This may 
be the reason behind the variability in the Bacoside A content of these formulations.  
The study  showed absence of Gold and presence of less amount of Bacoside A in two samples ,BV2 and BV3 ,which 
indicates their substandard quality and will lead to reduce their pharmacological properties than claimed in the traditional 
literatures. 
 
Conclusion 
  
Brahmi vati was standardized adopting modern analytical procedures and it was found that there are variations in 
the quality of the formulation prepared and marketed by different manufactures. The data of physico-chemical and elemental 
analysis of the standard Brahmi vote may be useful for evaluation and standardization. The proposed HPTLC method was 
found to be rapid, simple and accurate for quantitative estimation of Bacoside A. The method was found to be useful in 
detecting the genuineness of the formulation and thus suitable to evaluate various formulations of Brahmi vati available in the 
market.  
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